Koers Immunotech Laboratories, Inc. Other OTC
Aandelen
IMMB
US45254F2039
Biotechnologie & Medisch Onderzoek
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 57,5K 53,66K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 10,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Director/Board Member | 59 | 04-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,17% | 102 mld. | |
+2,87% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-14,77% | 21,4 mld. | |
-8,79% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-13,21% | 16,09 mld. | |
+8,55% | 13,83 mld. | |
+35,75% | 11,97 mld. |